Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jorge Cortes
Long-Term Molecular and Cytogenetic Response and Survival Outcomes With Imatinib 400 Mg, Imatinib 800 Mg, Dasatinib, and Nilotinib in Patients With Chronic-Phase Chronic Myeloid Leukaemia: Retrospective Analysis of Patient Data From Five Clinical Trials
The Lancet Haematology
Hematology
Long-Term Follow-Up of Lower Dose Dasatinib (50 Mg Daily) as Frontline Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Current Patient Management of Chronic Myeloid Leukemia in Latin America
Cancer
Cancer Research
Oncology
Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-Cvd, With or Without Blinatumomab, Is Highly Effective in Patients With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Salvage
Cancer
Cancer Research
Oncology
Experience With Rituximab Immunotherapy as an Early Intervention in Patients With Rai Stage 0 to II Chronic Lymphocytic Leukemia
Cancer
Cancer Research
Oncology
Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Estimations of the Increasing Prevalence and Plateau Prevalence of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitor Therapy
Cancer
Cancer Research
Oncology
Bone Marrow Core Biopsy in 508 Consecutive Patients With Chronic Myeloid Leukemia: Assessment of Potential Value
Cancer
Cancer Research
Oncology
Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
1
2
3
4
5
6
›
